OKUR OnKure Therapeutics, Inc. - Class A Common Stock
$4,35
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 4, 2026
Rango 52S
$2–$5
66% of range
Calificación del Analista
BUY
12 analysts
Precio Objetivo
$16
+256% upside
P/E (TTM)
-0.7
ROE
-88.6%
Margen de Beneficio Neto
-1733.7%
OKUR Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$4.35
Capitalización Bursátil
—
P/E (TTM)
-0.7
BPA (TTM)
$-4.40
Ingresos (TTM)
$0
Rendimiento div.
—
ROE
-88.6%
Deuda/Capital
—
Rango 52S
$2 – $5
OKUR Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$0
2024-12-31
→
2024-12-31
BPA
$-4.40
2020-12-31
→
2025-12-31
Flujo de caja libre
$-52M
2021-12-31
→
2025-12-31
Márgenes
-1733.7%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
OKUR
Mediana de Pares
P/E (TTM)
-0.7
1.2
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
OKUR
Mediana de Pares
Operating Margin (Margen Operativo)
-1833.7%
—
Net Profit Margin (Margen de Beneficio Neto)
-1733.7%
-1189.1%
ROA
-67.2%
-58.9%
ROE
-88.6%
-79.0%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
OKUR
Mediana de Pares
Current Ratio (Ratio corriente)
10.3
5.4
Quick Ratio (Ratio Rápido)
10.0
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
OKUR
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
OKUR
Mediana de Pares
OKUR Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
12 analistas
- Compra fuerte 4 33,3%
- Compra 6 50,0%
- Mantener 2 16,7%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
4 analistas · 2026-08-18
Mediana
$15.00
← Por Debajo de Todos los Objetivos
$4.35
Mín
$11.00
Máx
$21.00
Objetivo mediano
$15.00
+244,8%
Objetivo medio
$15.50
+256,3%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.11%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.31 | $-0.55 | 0.24% |
| 31 de marzo de 2026 | $-1.11 | $-0.76 | -0.35% |
| 31 de diciembre de 2025 | $-0.99 | $-1.18 | 0.18% |
| 30 de septiembre de 2025 | $-1.09 | $-1.22 | 0.13% |
| 30 de junio de 2025 | $-1.14 | $-1.27 | 0.13% |
| 31 de marzo de 2025 | $-1.19 | $-1.49 | 0.30% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| OKUR | — | -0.7 | — | -1733.7% | -88.6% | — |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | — |
| NKTX | $131M | -1.3 | — | — | -31.1% | — |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | — |
| CNTN | $112M | -2.7 | — | — | -18.0% | — |
| TNYA | $154M | -1.2 | — | — | -81.2% | — |
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | — |
| SPRB | $120M | -1.7 | -51.3% | — | -139.9% | — |
| EQ | $95M | -4.0 | 13.9% | — | -133.1% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 13
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue | · | $0 | |
| R&D Expense | $48M | $44M | |
| SG&A Expense | $15M | $11M | |
| Operating Expenses | $63M | $54M | |
| Operating Income | $-63M | $-54M | |
| Interest Income | $3M | $2M | |
| Income Tax | $0 | $0 | |
| Net Income | $-60M | $-53M | |
| EPS (Basic) | $-4.40 | $-15.28 | |
| EPS (Diluted) | $-4.40 | $-15.28 | |
| Shares (Basic) | 13,515,915 | 3,447,071 | |
| Shares (Diluted) | 13,515,915 | 3,447,071 | |
| EBITDA | $-63M | $-54M |
Balance general 19
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $59M | $111M | |
| Prepaid Expense | $2M | $2M | |
| Current Assets | $61M | $113M | |
| PP&E (Net) | $618.0K | $1M | |
| PP&E (Gross) | $2M | $2M | |
| Accum. Depreciation | $1M | $1M | |
| Other Non-current Assets | $273.0K | $109.0K | |
| Total Assets | $62M | $115M | |
| Accounts Payable | $1M | $3M | |
| Accrued Liabilities | · | $7M | |
| Current Liabilities | $6M | $11M | |
| Capital Leases | $0 | $549.0K | |
| Other Non-current Liabilities | $12.0K | · | |
| Total Liabilities | $6M | $11M | |
| Paid-in Capital | $270M | $259M | |
| Retained Earnings | $-214M | $-155M | |
| AOCI | $0 | · | |
| Stockholders' Equity | $56M | $104M | |
| Liabilities + Equity | $62M | $115M |
Flujo de Efectivo 9
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| D&A | $447.0K | $459.0K | |
| Stock-based Comp | $12M | $5M | |
| Other Non-cash | $-4M | $-3M | |
| Operating Cash Flow | $-52M | $-51M | |
| CapEx | $46.0K | $52.0K | |
| Investing Cash Flow | $-46.0K | $16M | |
| Financing Cash Flow | $163.0K | $116M | |
| Net Change in Cash | $-52M | $81M | |
| Free Cash Flow | $-52M | $-51M |
Rentabilidad 5
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -1833.7% | · | |
| Net Margin | -1733.7% | · | |
| EBITDA Margin | -1820.6% | · | |
| ROA | -67.2% | -69.9% | |
| ROE | -88.6% | 337.4% |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 10.3 | 10.7 | |
| Quick Ratio | 10.0 | 10.5 |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 |
Valoración (TTM) 4
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | · | $0 | |
| Net Income TTM | $-60M | $-53M | |
| P/E | -0.7 | -0.6 | |
| Earnings Yield | -151.7% | -177.7% |
Estado de resultados 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $12M | $11M | $12M | $13M | $13M | $14M | $10M | $11M | $9M | $-7M | $14M | $14M | $11M | $10M | $10M | |
| SG&A Expense | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $1M | $4M | $1M | $-14M | $7M | $7M | $5M | $4M | $4M | |
| Operating Expenses | $17M | $16M | $14M | $16M | $16M | $17M | $19M | $12M | $14M | $10M | $-21M | $21M | $21M | $16M | $15M | $14M | |
| Operating Income | $-17M | $-16M | $-14M | $-16M | $-16M | $-17M | $-19M | $-12M | $-14M | $-10M | $21M | $-21M | $-21M | $-16M | $-15M | $-14M | |
| Interest Income | $2M | $458.0K | $628.0K | $804.0K | $934.0K | $1M | $1M | $174.0K | $230.0K | $295.0K | · | · | · | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | $972.0K | $1M | $1M | · | $2M | $2M | $1M | $962.0K | $833.0K | |
| Net Income | $-15M | $-15M | $-14M | $-15M | $-15M | $-16M | $-17M | $-12M | $-14M | $-10M | $19M | $-19M | $-20M | $-15M | $-14M | $-13M | |
| EPS (Basic) | $-0.31 | $-1.11 | $-0.98 | $-1.09 | $-1.14 | $-1.19 | $96.46 | $-36.55 | $-44.82 | $-30.37 | $-117.48 | $-5.68 | $-0.65 | $-0.60 | $-0.56 | $-0.53 | |
| EPS (Diluted) | $-0.31 | $-1.11 | $-0.98 | $-1.09 | $-1.14 | $-1.19 | $96.46 | $-36.55 | $-44.82 | $-30.37 | $-117.48 | $-5.68 | $-0.65 | $-0.60 | $-0.56 | $-0.53 | |
| Shares (Basic) | 49,869,177 | 13,674,577 | -26,948,392 | 13,530,892 | 13,509,080 | 13,424,335 | 2,501,435 | 316,142 | 315,478 | 314,016 | -58,348,708 | 3,380,794 | 30,215,321 | 25,036,410 | -48,922,002 | 24,496,313 | |
| Shares (Diluted) | 49,869,177 | 13,674,577 | -26,948,392 | 13,530,892 | 13,509,080 | 13,424,335 | 2,501,435 | 316,142 | 315,478 | 314,016 | -58,348,708 | 3,380,794 | 30,215,321 | 25,036,410 | -48,922,002 | 24,496,313 | |
| EBITDA | $-17M | $-16M | · | $-15M | $-16M | $-17M | · | $-5M | $-6M | $-10M | · | $-21M | $-21M | $-16M | · | $-14M |
Balance general 22
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167M | $192M | $59M | $70M | $83M | $97M | $111M | $61M | $36M | $20M | $30M | $12M | $9M | $30M | $20M | $62M | |
| Short-term Investments | · | · | · | · | · | · | · | $16M | $41M | $62M | · | $114M | $134M | $63M | $81M | $54M | |
| Prepaid Expense | $1M | $5M | $2M | $1M | $1M | $2M | $2M | $331.0K | $1M | $1M | $4M | $3M | $4M | $3M | $5M | $5M | |
| Current Assets | $178M | $197M | $61M | $72M | $85M | $98M | $113M | $77M | $78M | $84M | $34M | $129M | $146M | $97M | $106M | $121M | |
| PP&E (Net) | $435.0K | $519.0K | $618.0K | $720.0K | $821.0K | $925.0K | $1M | $59.0K | $81.0K | $102.0K | $1M | $529.0K | $554.0K | $581.0K | $453.0K | $241.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | $2M | · | · | · | $555.0K | · | |
| Accum. Depreciation | $2M | $2M | $1M | $1M | $1M | $1M | $1M | · | · | · | $665.0K | · | · | · | $102.0K | · | |
| Other Non-current Assets | $401.0K | $405.0K | $273.0K | $104.0K | $116.0K | $109.0K | $109.0K | $147.0K | $153.0K | $64.0K | $58.0K | $81.0K | $79.0K | $81.0K | $84.0K | $79.0K | |
| Total Assets | $179M | $199M | $62M | $73M | $86M | $100M | $115M | $78M | $79M | $85M | $36M | $130M | $148M | $99M | $108M | $123M | |
| Accounts Payable | $2M | $11M | $1M | $1M | $2M | $2M | $3M | $237.0K | $64.0K | $676.0K | $3M | $2M | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | $5M | $6M | · | $725.0K | $953.0K | $2M | $4M | $11M | $12M | $8M | $5M | $7M | |
| Current Liabilities | $7M | $14M | $6M | $6M | $8M | $9M | $11M | $3M | $1M | $3M | $7M | $14M | $14M | $10M | $7M | $9M | |
| Capital Leases | $590.0K | $0 | · | $120.0K | $267.0K | $409.0K | $549.0K | $379.0K | $492.0K | $576.0K | $466.0K | $812.0K | $897.0K | $979.0K | $1M | $943.0K | |
| Other Non-current Liabilities | $12.0K | $12.0K | $12.0K | $40.0K | $40.0K | $40.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $7M | $14M | $6M | $6M | $8M | $9M | $11M | $4M | $2M | $3M | $8M | $15M | $16M | $12M | $8M | $10M | |
| Common Stock | · | · | · | · | · | · | · | $0 | $3.0K | $3.0K | · | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $417M | $414M | $270M | $267M | $264M | $261M | $259M | $310M | $309M | $308M | $209.0K | $305M | $304M | $239M | $237M | $235M | |
| Retained Earnings | $-245M | $-229M | $-214M | $-201M | $-186M | $-171M | $-155M | $-236M | $-232M | $-227M | $-102M | $-191M | $-171M | $-152M | $-137M | $-123M | |
| AOCI | $-13.0K | · | · | · | · | · | · | $2.0K | $-13.0K | $-12.0K | · | $-21.0K | $-31.0K | $12.0K | $-43.0K | $-26.0K | |
| Stockholders' Equity | $172M | $184M | $56M | $66M | $78M | $91M | $104M | $74M | $77M | $81M | $-102M | $115M | $133M | $87M | $100M | $112M | |
| Liabilities + Equity | $179M | $199M | $62M | $73M | $86M | $100M | $115M | $78M | $79M | $85M | $36M | $130M | $148M | $99M | $108M | $123M | |
| Shares Outstanding | · | · | · | · | · | · | · | 3,343,525 | 33,420,808 | 33,420,808 | · | 33,872,166 | 33,800,788 | 25,107,430 | 24,699,553 | 24,529,646 |
Flujo de Efectivo 11
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $87.0K | $104.0K | $104.0K | $108.0K | $117.0K | $118.0K | $116.0K | $114.0K | $115.0K | $114.0K | $291.0K | $43.0K | $42.0K | $41.0K | $25.0K | $22.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $-70.0K | $842.0K | $107.0K | $-4M | $1M | $1M | $1M | $1M | $990.0K | |
| Other Non-cash | · | $-665.0K | · | · | · | $-943.0K | · | · | · | $-14M | · | · | · | $5M | · | · | |
| Operating Cash Flow | $-10M | $-13M | $-12M | $-13M | $-13M | $-14M | $-23M | $58.0K | $4M | $-11M | $9M | $-19M | $-16M | $-9M | $-16M | $-11M | |
| CapEx | $3.0K | $5.0K | $9.0K | $6.0K | $13.0K | $18.0K | $15.0K | $35.0K | $10.0K | $9.0K | $50.0K | $19.0K | $5.0K | $172.0K | $250.0K | $28.0K | |
| Investing Cash Flow | $-10M | $-5.0K | $-9.0K | $-6.0K | $-13.0K | $-18.0K | $16M | $-36M | $-14M | $-9.0K | $29M | $21M | $-69M | $19M | $-27M | $-45M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-5M | $146M | $240.0K | $0 | $0 | $-77.0K | $110M | $6M | $6M | $10.0K | $-12M | $173.0K | $64M | $1M | $325.0K | $97.0K | |
| Net Change in Cash | $-26M | $133M | $-11M | $-13M | $-13M | $-14M | $103M | $-30M | $-4M | $-11M | $27M | $3M | $-21M | $10M | $-42M | $-56M | |
| Free Cash Flow | · | $-13M | · | · | · | $-14M | · | · | · | · | · | · | · | $-9M | · | · |
Rentabilidad 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1088.2% | -3409.4% | · | -1932.8% | -1747.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -988.2% | -3309.4% | · | -1832.8% | -1647.8% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1088.2% | -3386.7% | · | -1919.3% | -1735.2% | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -11.6% | -10.2% | · | -19.5% | -18.7% | -17.3% | · | -3.5% | -4.7% | -9.2% | · | -15.2% | -13.9% | -12.4% | · | -9.1% | |
| ROE | -12.3% | -11.0% | · | -20.9% | -19.9% | -18.5% | · | -3.9% | -5.1% | -10.0% | · | -16.9% | -15.2% | -13.6% | · | -9.7% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.7 | 13.8 | · | 11.4 | 11.1 | 11.2 | · | 23.7 | 57.9 | 29.8 | · | 9.5 | 10.7 | 9.3 | · | 12.8 | |
| Quick Ratio | 25.1 | 13.4 | · | 11.3 | 11.0 | 11.0 | · | 23.6 | 56.9 | 29.4 | · | 9.3 | 10.4 | 8.9 | · | 12.3 |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-59M | $-59M | · | $-63M | $-60M | $-59M | · | $-54M | $-62M | $-63M | · | $-67M | $-60M | $-53M | · | $-51M | |
| Market Cap | · | · | · | · | · | · | · | $57M | $505M | $555M | · | $2.58B | $2.22B | $1.50B | · | $822M | |
| P/E | -1.2 | -0.9 | · | -0.1 | -0.0 | -0.0 | · | -0.1 | -0.2 | -0.4 | · | -10.2 | -28.8 | -27.7 | · | -16.1 | |
| P/B | · | · | · | · | · | · | · | 0.8 | 6.6 | 6.8 | · | 22.4 | 16.7 | 17.2 | · | 7.3 | |
| P / Tangible Book | · | · | · | · | · | · | · | 0.8 | 6.6 | 6.8 | · | 22.4 | 16.7 | 17.2 | · | 7.3 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | · | -26.4 | · | · | · | -165.9 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -162.8 | · | · | |
| Earnings Yield | -80.0% | -109.4% | · | -1453.5% | -3502.1% | -2626.3% | · | -690.7% | -539.9% | -224.7% | · | -9.8% | -3.5% | -3.6% | · | -6.2% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | — | $0 | — | — | — |
| Margen Operativo % | -1833.7% | — | — | — | — |
| Beneficio neto | $-60M | $-53M | $-35M | $-52M | $-40M |
| EPS Diluido | $-4.40 | $-15.28 | $-124.41 | $-2.12 | $-2.19 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 10.3 | 10.7 | — | 14.9 | 24.8 |
| Ratio Rápido | 10.0 | 10.5 | — | 14.2 | 23.8 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-52M | $-51M | — | $-48M | $-38M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 78 declarantes · $148.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 34 (+16 vs trimestre anterior) | 8 (+1 vs trimestre anterior) | 14 (+1 vs trimestre anterior) | 13 (+1 vs trimestre anterior) | +2.7M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $18 232 398 | 3 998 333 | 12,25% | Acciones |
| BVF INC/IL | $14 755 148 | 3 235 778 | 9,91% | Acciones |
| ACORN CAPITAL ADVISORS, LLC | $12 948 913 | 2 839 674 | 8,70% | Acciones |
| StepStone Group LP | $11 014 934 | 2 660 612 | 7,40% | Acciones |
| ADAR1 Capital Management, LLC | $10 208 399 | 2 238 684 | 6,86% | Acciones |
| Vivo Capital, LLC | $8 790 358 | 1 927 710 | 5,91% | Acciones |
| Vestal Point Capital, LP | $8 325 187 | 1 825 699 | 5,59% | Acciones |
| Trails Edge Capital Partners, LP | $6 559 359 | 1 438 456 | 4,41% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $6 552 898 | 1 437 039 | 4,40% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $5 493 975 | 1 204 819 | 3,69% | Acciones |
| CITADEL ADVISORS LLC | $5 412 934 | 1 187 047 | 3,64% | Acciones |
| Sio Capital Management, LLC | $4 920 080 | 1 078 965 | 3,31% | Acciones |
| Prosight Management, LP | $4 464 204 | 978 992 | 3,00% | Acciones |
| Logos Global Management LP | $4 395 179 | 963 855 | 2,95% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $2 788 902 | 611 596 | 1,87% | Acciones |
| NEA Management Company, LLC | $2 182 179 | 478 548 | 1,47% | Acciones |
| STATE STREET CORP | $2 114 299 | 463 662 | 1,42% | Acciones |
| Ensign Peak Advisors, Inc | $1 968 237 | 431 631 | 1,32% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 635 845 | 358 738 | 1,10% | Acciones |
| Sofinnova Investments, Inc. | $1 466 916 | 321 692 | 0,99% | Acciones |
| Carlyle Group Inc. | $1 230 721 | 269 895 | 0,83% | Acciones |
| Seven Fleet Capital Management LP | $1 098 791 | 240 963 | 0,74% | Acciones |
| Affinity Asset Advisors, LLC | $1 098 791 | 240 963 | 0,74% | Acciones |
| DV EQUITIES, LLC | $1 098 791 | 240 963 | 0,74% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $810 613 | 177 766 | 0,54% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $753 207 | 165 177 | 0,51% | Acciones |
| Rosalind Advisors, Inc. | $684 000 | 150 000 | 0,46% | Acciones |
| Stonepine Capital Management, LLC | $595 919 | 130 684 | 0,40% | Acciones |
| KOTLER KEVIN | $573 304 | 197 691 | 0,39% | Acciones |
| Longaeva Partners L.P. | $549 398 | 120 482 | 0,37% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $496 447 | 108 870 | 0,33% | Acciones |
| BANK OF AMERICA CORP /DE/ | $484 819 | 106 320 | 0,33% | Acciones |
| CANTOR FITZGERALD, L. P. | $456 064 | 100 014 | 0,31% | Acciones |
| UBS Group AG | $454 194 | 99 604 | 0,31% | Acciones |
| Rangeley Capital, LLC | $433 200 | 95 000 | 0,29% | Acciones |
| Aisling Capital Management LP | $404 048 | 88 607 | 0,27% | Acciones |
| Walleye Capital LLC | $324 230 | 71 103 | 0,22% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $290 198 | 63 640 | 0,19% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $229 336 | 50 293 | 0,15% | Acciones |
| Shay Capital LLC | $228 000 | 50 000 | 0,15% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $221 766 | 48 633 | 0,15% | Acciones |
| PRELUDE CAPITAL MANAGEMENT, LLC | $212 916 | 46 692 | 0,14% | Acciones |
| Aldebaran Capital, LLC | $181 803 | 39 869 | 0,12% | Acciones |
| Nuveen, LLC | $161 433 | 35 402 | 0,11% | Acciones |
| Verdad Advisers, LP | $130 690 | 28 660 | 0,09% | Acciones |
| Bank of New York Mellon Corp | $119 705 | 26 251 | 0,08% | Acciones |
| DEUTSCHE BANK AG\ | $116 572 | 25 564 | 0,08% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $105 231 | 23 077 | 0,07% | Acciones |
| WELLS FARGO & COMPANY/MN | $100 097 | 21 951 | 0,07% | Acciones |
| RHUMBLINE ADVISERS | $95 736 | 20 996 | 0,06% | Acciones |
| Jump Financial, LLC | $93 024 | 20 400 | 0,06% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $90 694 | 19 889 | 0,06% | Acciones |
| MARSHALL WACE, LLP | $83 744 | 18 365 | 0,06% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $82 536 | 18 100 | 0,06% | Acciones |
| XTX Topco Ltd | $77 383 | 16 970 | 0,05% | Acciones |
| TWO SIGMA ADVISERS, LP | $77 163 | 26 608 | 0,05% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $55 035 | 12 069 | 0,04% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $51 473 | 11 288 | 0,03% | Acciones |
| CITIGROUP INC | $48 687 | 10 677 | 0,03% | Acciones |
| Invesco Ltd. | $47 657 | 10 451 | 0,03% | Acciones |
| Police & Firemen's Retirement System of New Jersey | $47 073 | 10 323 | 0,03% | Acciones |
| MORGAN STANLEY | $29 900 | 6 557 | 0,02% | Acciones |
| BARCLAYS PLC | $20 520 | 4 500 | 0,01% | Acciones |
| NORTHERN TRUST CORP | $18 778 | 4 118 | 0,01% | Acciones |
| Legal & General Group Plc | $11 651 | 2 555 | 0,01% | Acciones |
| Ameritas Investment Partners, Inc. | $10 848 | 2 379 | 0,01% | Acciones |
| Russell Investments Group, Ltd. | $9 557 | 2 096 | 0,01% | Acciones |
| Tower Research Capital LLC (TRC) | $7 346 | 1 611 | 0,00% | Acciones |
| BlackRock, Inc. | $6 644 | 1 457 | 0,00% | Acciones |
| ROYAL BANK OF CANADA | $4 000 | 966 | 0,00% | Acciones |
| Sterling Capital Management LLC | $2 408 | 528 | 0,00% | Acciones |
| VANGUARD GROUP INC | $2 161 | 745 | 0,00% | Acciones |
| TRUST CO OF TOLEDO NA /OH/ | $620 | 136 | 0,00% | Acciones |
| OSAIC HOLDINGS, INC. | $410 | 90 | 0,00% | Acciones |
| FMR LLC | $406 | 89 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $203 | 45 | 0,00% | Acciones |
| PRICE T ROWE ASSOCIATES INC /MD/ | $98 | 21 481 | 0,00% | Acciones |
| T. Rowe Price Investment Management, Inc. | $70 | 15 335 | 0,00% | Acciones |
Informantes de la empresa 28 insiders · 6 directivos · 9 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Gregory J. Flesher | President and CEO | 9 de diciembre de 2022 A | 109 600 | 0 | 0 | $0 |
| Michael Cruse | Chief Operating Officer | 9 de diciembre de 2022 A | 13 697 | 0 | 0 | $0 |
| Ashley Hall | Chief Development Officer | 28 de agosto de 2023 M | 39 600 | 0 | 0 | $0 |
| Jennifer Lam | VP of Finance & Administration | 9 de diciembre de 2022 A | — | 0 | 0 | $0 |
| Alejandro Dorenbaum | Chief Medical Officer | 9 de diciembre de 2022 A | 30 000 | 0 | 0 | $0 |
| Wendy S. Johnson | Chief Development Officer | 14 de julio de 2021 S | 0 | 0 | 0 | $0 |
| Roshawn A. Blunt | Consejero | 6 de junio de 2023 A | — | 0 | 0 | $0 |
| Bali Muralidhar | Consejero | 6 de junio de 2023 A | 2 073 957 | 0 | 0 | $0 |
| Niall O'Donnell, Ph.D. | Consejero | 6 de junio de 2023 A | 2 188 713 | 0 | 0 | $0 |
| Eric M Dube | Consejero | 6 de junio de 2023 A | — | 0 | 0 | $0 |
| Stacey Denenberg Seltzer | Consejero | 6 de junio de 2023 A | — | 0 | 0 | $0 |
| Paul W. Hoelscher | Consejero | 6 de junio de 2023 A | — | 0 | 0 | $0 |
| Lon Cardon | Consejero | 8 de abril de 2021 A | — | 0 | 0 | $0 |
| Kenneth Harrison Ph.D. | Consejero | 8 de abril de 2021 A | — | 0 | 0 | $0 |
| Novo Holdings A/S | Propietario del 10% | 23 de junio de 2023 S | 3 330 337 | 0 | 0 | $0 |
| Dylan Hartley | — | 7 de agosto de 2026 A | — | 0 | 0 | $0 |
| Andrew John Phillips | — | 7 de agosto de 2026 A | — | 0 | 0 | $0 |
| Valerie Malyvanh Jansen | — | 7 de agosto de 2026 A | — | 0 | 0 | $0 |
| Samuel Agresta | — | 7 de agosto de 2026 A | — | 0 | 0 | $0 |
| Jason A. Leverone | — | 7 de agosto de 2026 A | 18 802 | 0 | 1 | $-1 333 |
| Michael R Carruthers | — | 7 de agosto de 2026 A | — | 0 | 0 | $0 |
| Isaac Manke | — | 7 de agosto de 2026 A | — | 0 | 0 | $0 |
| Nicholas A Saccomano | — | 7 de agosto de 2026 A | 11 247 | 0 | 1 | $-378 |
| Liam Ratcliffe | — | 7 de agosto de 2026 A | — | 0 | 0 | $0 |
| Edward T. Mathers | — | 7 de agosto de 2026 A | 15 310 | 0 | 0 | $0 |
| Michael G Grey | — | 7 de agosto de 2026 A | 0 | 0 | 0 | $0 |
| Leonard Braden Michael | — | 7 de octubre de 2024 J | 102 076 | 0 | 0 | $0 |
| Vineet R. Jindal | — | 10 de diciembre de 2021 A | 36 600 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 10 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| AI Biotechnology LLC, Access Industries Holdings LLC, Access Industries Management, LLC, Len Blavatnik | 7 de abril de 2026 | 19,99% | Presentación inicial | Inversión pasiva | SEC |
| ACORN BIOVENTURES, L.P., ACORN CAPITAL ADVISORS GP, LLC, Anders Hove, ACORN BIOVENTURES 2, L.P., Acorn Capital Advisors GP 2, LLC ×2 presentaciones | 30 de mayo de 2025 | 22,10% | Enmienda | M&A / venta | SEC |
| RiverVest Venture Fund III, L.P., RiverVest Venture Fund III (Ohio), L.P., RiverVest Venture Partners III (Ohio), LLC, RiverVest Venture Partners III, L.P., RiverVest Venture Partners III, LLC, RiverVest Venture Fund IV, L.P., RiverVest Venture Partners IV, L.P., RiverVest Venture Partners IV, LLC, John P. McKearn, Ph.D., Jay Schmelter, Thomas C. Melzer, Niall O'Donnell, Ph.D. | 21 de enero de 2025 | 1,55% | Enmienda | — | SEC |
| 8 de octubre de 2024 | — | Presentación inicial | — | SEC | |
| New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×2 presentaciones | 8 de mayo de 2024 | — | Presentación inicial | — | SEC |
| TANG CAPITAL PARTNERS, LP, TANG CAPITAL MANAGEMENT, LLC, KEVIN TANG, Concentra Biosciences, LLC | 26 de diciembre de 2023 | — | Presentación inicial | Inversión pasiva | SEC |
| Novo Holdings A/S ×5 presentaciones | 15 de diciembre de 2023 | — | Presentación inicial | — | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 30 de mayo de 2023 | — | Presentación inicial | — | SEC |
| Abingworth LLP, Abingworth Bioventures 8, LP | 20 de abril de 2021 | — | Presentación inicial | Inversión pasiva | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 19 de abril de 2021 | — | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 5 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 8 831 NS | 31 de mayo de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 21 147 NS | 30 de abril de 2026 | N-PORT |
| IWN · iShares Trust | — | — | 17 de agosto de 2026 | Diario |
| IWM · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWC · iShares Trust | — | — | 18 de agosto de 2026 | Diario |